Loading…
Real-world effectiveness of genotype-specific and pangenotypic direct-acting antivirals in HCV-infected patients with renal failure
Saved in:
Published in: | Clinical and experimental hepatology 2023-12, Vol.9 (4), p.320-334 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 334 |
container_issue | 4 |
container_start_page | 320 |
container_title | Clinical and experimental hepatology |
container_volume | 9 |
creator | Tronina, Olga Brzdęk, Michał Zarębska-Michaluk, Dorota Lorenc, Beata Janocha-Litwin, Justyna Berak, Hanna Sitko, Marek Dybowska, Dorota Mazur, Włodzimierz Tudrujek-Zdunek, Magdalena Janczewska, Ewa Klapaczyński, Jakub Dobracki, Witold Parfieniuk-Kowerda, Anna Krygier, Rafał Socha, Łukasz Flisiak, Robert |
description | |
doi_str_mv | 10.5114/ceh.2023.133307 |
format | article |
fullrecord | <record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11103803</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_11103803</sourcerecordid><originalsourceid>FETCH-LOGICAL-c348t-ca6de5d68559d14f30fc6f6f11e2f4370dab579fb511715ac1132961a1a946953</originalsourceid><addsrcrecordid>eNpVkE1LAzEQhoMottSeveYPpGZ2sh85iRS1QkEQ9bpks5M2sM0uu9uWnv3jptiLpxnm4Xl5GcbuQS5SAPVgabtIZIILQESZX7FpopQWRYLFddxRJwKk1hM2HwZfSaVyREB5yyZY5LkCnU3ZzweZRhzbvqk5OUd29AcKNAy8dXxDoR1PHYmhI-udt9yEmncmXEA81L6PjjDRC5uIo-570wzcB75afgsfzpl0tkZPYRz40Y9b3lMwDXfGN_ue7tiNiwrNL3PGvl6eP5crsX5_fVs-rYVFVYzCmqymtM6KNNU1KIfS2cxlDoASpzCXtanSXLsqPieH1FgATHQGBoxWmU5xxh7_crt9taPaxjqxatn1fmf6U9kaX_4nwW_LTXsoAUBiIRF_AQf_cvg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Real-world effectiveness of genotype-specific and pangenotypic direct-acting antivirals in HCV-infected patients with renal failure</title><source>PubMed Central</source><creator>Tronina, Olga ; Brzdęk, Michał ; Zarębska-Michaluk, Dorota ; Lorenc, Beata ; Janocha-Litwin, Justyna ; Berak, Hanna ; Sitko, Marek ; Dybowska, Dorota ; Mazur, Włodzimierz ; Tudrujek-Zdunek, Magdalena ; Janczewska, Ewa ; Klapaczyński, Jakub ; Dobracki, Witold ; Parfieniuk-Kowerda, Anna ; Krygier, Rafał ; Socha, Łukasz ; Flisiak, Robert</creator><creatorcontrib>Tronina, Olga ; Brzdęk, Michał ; Zarębska-Michaluk, Dorota ; Lorenc, Beata ; Janocha-Litwin, Justyna ; Berak, Hanna ; Sitko, Marek ; Dybowska, Dorota ; Mazur, Włodzimierz ; Tudrujek-Zdunek, Magdalena ; Janczewska, Ewa ; Klapaczyński, Jakub ; Dobracki, Witold ; Parfieniuk-Kowerda, Anna ; Krygier, Rafał ; Socha, Łukasz ; Flisiak, Robert</creatorcontrib><identifier>ISSN: 2392-1099</identifier><identifier>EISSN: 2449-8238</identifier><identifier>DOI: 10.5114/ceh.2023.133307</identifier><identifier>PMID: 38774196</identifier><language>eng</language><publisher>Termedia Publishing House</publisher><subject>Original Paper</subject><ispartof>Clinical and experimental hepatology, 2023-12, Vol.9 (4), p.320-334</ispartof><rights>Copyright: © 2023 Clinical and Experimental Hepatology 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11103803/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11103803/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids></links><search><creatorcontrib>Tronina, Olga</creatorcontrib><creatorcontrib>Brzdęk, Michał</creatorcontrib><creatorcontrib>Zarębska-Michaluk, Dorota</creatorcontrib><creatorcontrib>Lorenc, Beata</creatorcontrib><creatorcontrib>Janocha-Litwin, Justyna</creatorcontrib><creatorcontrib>Berak, Hanna</creatorcontrib><creatorcontrib>Sitko, Marek</creatorcontrib><creatorcontrib>Dybowska, Dorota</creatorcontrib><creatorcontrib>Mazur, Włodzimierz</creatorcontrib><creatorcontrib>Tudrujek-Zdunek, Magdalena</creatorcontrib><creatorcontrib>Janczewska, Ewa</creatorcontrib><creatorcontrib>Klapaczyński, Jakub</creatorcontrib><creatorcontrib>Dobracki, Witold</creatorcontrib><creatorcontrib>Parfieniuk-Kowerda, Anna</creatorcontrib><creatorcontrib>Krygier, Rafał</creatorcontrib><creatorcontrib>Socha, Łukasz</creatorcontrib><creatorcontrib>Flisiak, Robert</creatorcontrib><title>Real-world effectiveness of genotype-specific and pangenotypic direct-acting antivirals in HCV-infected patients with renal failure</title><title>Clinical and experimental hepatology</title><subject>Original Paper</subject><issn>2392-1099</issn><issn>2449-8238</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpVkE1LAzEQhoMottSeveYPpGZ2sh85iRS1QkEQ9bpks5M2sM0uu9uWnv3jptiLpxnm4Xl5GcbuQS5SAPVgabtIZIILQESZX7FpopQWRYLFddxRJwKk1hM2HwZfSaVyREB5yyZY5LkCnU3ZzweZRhzbvqk5OUd29AcKNAy8dXxDoR1PHYmhI-udt9yEmncmXEA81L6PjjDRC5uIo-570wzcB75afgsfzpl0tkZPYRz40Y9b3lMwDXfGN_ue7tiNiwrNL3PGvl6eP5crsX5_fVs-rYVFVYzCmqymtM6KNNU1KIfS2cxlDoASpzCXtanSXLsqPieH1FgATHQGBoxWmU5xxh7_crt9taPaxjqxatn1fmf6U9kaX_4nwW_LTXsoAUBiIRF_AQf_cvg</recordid><startdate>20231201</startdate><enddate>20231201</enddate><creator>Tronina, Olga</creator><creator>Brzdęk, Michał</creator><creator>Zarębska-Michaluk, Dorota</creator><creator>Lorenc, Beata</creator><creator>Janocha-Litwin, Justyna</creator><creator>Berak, Hanna</creator><creator>Sitko, Marek</creator><creator>Dybowska, Dorota</creator><creator>Mazur, Włodzimierz</creator><creator>Tudrujek-Zdunek, Magdalena</creator><creator>Janczewska, Ewa</creator><creator>Klapaczyński, Jakub</creator><creator>Dobracki, Witold</creator><creator>Parfieniuk-Kowerda, Anna</creator><creator>Krygier, Rafał</creator><creator>Socha, Łukasz</creator><creator>Flisiak, Robert</creator><general>Termedia Publishing House</general><scope>5PM</scope></search><sort><creationdate>20231201</creationdate><title>Real-world effectiveness of genotype-specific and pangenotypic direct-acting antivirals in HCV-infected patients with renal failure</title><author>Tronina, Olga ; Brzdęk, Michał ; Zarębska-Michaluk, Dorota ; Lorenc, Beata ; Janocha-Litwin, Justyna ; Berak, Hanna ; Sitko, Marek ; Dybowska, Dorota ; Mazur, Włodzimierz ; Tudrujek-Zdunek, Magdalena ; Janczewska, Ewa ; Klapaczyński, Jakub ; Dobracki, Witold ; Parfieniuk-Kowerda, Anna ; Krygier, Rafał ; Socha, Łukasz ; Flisiak, Robert</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c348t-ca6de5d68559d14f30fc6f6f11e2f4370dab579fb511715ac1132961a1a946953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Original Paper</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tronina, Olga</creatorcontrib><creatorcontrib>Brzdęk, Michał</creatorcontrib><creatorcontrib>Zarębska-Michaluk, Dorota</creatorcontrib><creatorcontrib>Lorenc, Beata</creatorcontrib><creatorcontrib>Janocha-Litwin, Justyna</creatorcontrib><creatorcontrib>Berak, Hanna</creatorcontrib><creatorcontrib>Sitko, Marek</creatorcontrib><creatorcontrib>Dybowska, Dorota</creatorcontrib><creatorcontrib>Mazur, Włodzimierz</creatorcontrib><creatorcontrib>Tudrujek-Zdunek, Magdalena</creatorcontrib><creatorcontrib>Janczewska, Ewa</creatorcontrib><creatorcontrib>Klapaczyński, Jakub</creatorcontrib><creatorcontrib>Dobracki, Witold</creatorcontrib><creatorcontrib>Parfieniuk-Kowerda, Anna</creatorcontrib><creatorcontrib>Krygier, Rafał</creatorcontrib><creatorcontrib>Socha, Łukasz</creatorcontrib><creatorcontrib>Flisiak, Robert</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical and experimental hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tronina, Olga</au><au>Brzdęk, Michał</au><au>Zarębska-Michaluk, Dorota</au><au>Lorenc, Beata</au><au>Janocha-Litwin, Justyna</au><au>Berak, Hanna</au><au>Sitko, Marek</au><au>Dybowska, Dorota</au><au>Mazur, Włodzimierz</au><au>Tudrujek-Zdunek, Magdalena</au><au>Janczewska, Ewa</au><au>Klapaczyński, Jakub</au><au>Dobracki, Witold</au><au>Parfieniuk-Kowerda, Anna</au><au>Krygier, Rafał</au><au>Socha, Łukasz</au><au>Flisiak, Robert</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Real-world effectiveness of genotype-specific and pangenotypic direct-acting antivirals in HCV-infected patients with renal failure</atitle><jtitle>Clinical and experimental hepatology</jtitle><date>2023-12-01</date><risdate>2023</risdate><volume>9</volume><issue>4</issue><spage>320</spage><epage>334</epage><pages>320-334</pages><issn>2392-1099</issn><eissn>2449-8238</eissn><pub>Termedia Publishing House</pub><pmid>38774196</pmid><doi>10.5114/ceh.2023.133307</doi><tpages>15</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2392-1099 |
ispartof | Clinical and experimental hepatology, 2023-12, Vol.9 (4), p.320-334 |
issn | 2392-1099 2449-8238 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11103803 |
source | PubMed Central |
subjects | Original Paper |
title | Real-world effectiveness of genotype-specific and pangenotypic direct-acting antivirals in HCV-infected patients with renal failure |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T02%3A56%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Real-world%20effectiveness%20of%20genotype-specific%20and%20pangenotypic%20direct-acting%20antivirals%20in%20HCV-infected%20patients%20with%20renal%20failure&rft.jtitle=Clinical%20and%20experimental%20hepatology&rft.au=Tronina,%20Olga&rft.date=2023-12-01&rft.volume=9&rft.issue=4&rft.spage=320&rft.epage=334&rft.pages=320-334&rft.issn=2392-1099&rft.eissn=2449-8238&rft_id=info:doi/10.5114/ceh.2023.133307&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_11103803%3C/pubmedcentral%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c348t-ca6de5d68559d14f30fc6f6f11e2f4370dab579fb511715ac1132961a1a946953%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/38774196&rfr_iscdi=true |